Nepalact
Brand Name: Nepalact
Generic Name: Nepafenac
Active
Registration Number
DR-XY45971
Dosage Form
Sterile Ophthalmic Suspension (Eye Drops)
Issuance Date
August 7, 2024
Expiry Date
August 7, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1 mg/mL (0.1% w/v)
Packaging5 mL (net content) translucent LDPE dropper bottle with translucent LDPE plug and opaque white HDPE pilfer-proof cap (Box of 1's)
Classification
C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Non-Steroidal Anti-inflammatory Drug (NSAID)
A
Application
Initial (from Monitored Release)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
NepafenacActive
Monograph: Nepafenac